Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label flexible-dose follow-up study of pramipexole in children and adolescents with Tourette syndrome
2008-000342-32Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pramipexole in Tourette syndrome (TS), sponsored by Boehringer Ingelheim. Primary endpoints: Safety endpoints and Efficacy endpoints. Started Dec 2008; status: terminated.
02
Drugs
pramipexole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on 2008-000342-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000342-32.